ZILBRYSQ Logo (WIPO, 04/21/2021)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ZILBRYSQ was filed as Figurative mark on 04/21/2021 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing #Colours #Three predominant colours
| Trademark form | Figurative mark |
| File reference | 1593154 |
| Countries | 
|
| Base trademark |
No. 90286947,
October 29, 2020
|
| Application date | April 21, 2021 |
| Expiration date | April 21, 2031 |
Trademark owner
87 Cambridge Park Drive
Cambridge MA 02140
US
Cambridge MA 02140
US
Trademark representatives
Drakestr. 58
12205 Berlin
DE
goods and services
05
Pharmaceutical preparations, for human use, for the
prevention and treatment of paroxysmal nocturnal
hemoglobinuria, myasthenia gravis, an inflammatory
indication, a wound, a burn, an autoimmune indication, a
pulmonary indication, a cardiovascular indication, a
neurological indication, a kidney-related indication, a
diabetes-related indication, an ocular indication, and a
pregnancy-related indication; pharmaceutical preparations,
for human use, for the prevention and treatment of disorders
of metabolism, the nervous system, the immune system, the
cardio-vascular system, the respiratory system, the
musculoskeletal system, and the genitourinary system;
pharmaceutical preparations for the treatment of fibrotic
and inflammatory disorders; pharmaceutical preparations for
use in dermatology, nephrology, hepatology, rheumatology,
oncology, hematology and in tissue and organ
transplantation, in ophthalmology and for
gastroenterological disorders; pharmaceutical preparations
as anti-viral, antibacterial, and anti-fungal agents
10
Syringes for injections; syringes for medical purposes;
syringes for medical purposes sold empty which may be filled
with pharmaceutical preparations, for human use, for the
prevention and treatment of paroxysmal nocturnal
hemoglobinuria, myasthenia gravis, an inflammatory
indication, a wound, a burn, an autoimmune indication, a
pulmonary indication, a cardiovascular indication, a
neurological indication, a kidney-related indication, a
diabetes-related indication, an ocular indication, and a
pregnancy-related indication
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 26, 2022 | 2022/43 Gaz | IS | Rejection |
| July 4, 2022 | 2022/27 Gaz | MX | Rejection |
| June 22, 2022 | 2022/25 Gaz | BR | Rejection |
| May 2, 2022 | 2022/19 Gaz | KR | Rejection |
| May 2, 2022 | 2022/24 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 6, 2022 | 2022/14 Gaz | CH | Rejection |
| March 29, 2022 | 2022/13 Gaz | NO | Rejection |
| March 3, 2022 | 2022/10 Gaz | CA | Rejection |
| February 3, 2022 | 2022/5 Gaz | CO | Rejection |
| December 13, 2021 | 2021/50 Gaz | TR | Rejection |
| November 30, 2021 | 2021/48 Gaz | NZ | Rejection |
| October 13, 2021 | 2021/41 Gaz | GB | Rejection |
| October 5, 2021 | 2021/42 Gaz | IL | Rejection |
| August 16, 2021 | 2021/33 Gaz | RU | Rejection |
| August 11, 2021 | 2021/32 Gaz | AU | Rejection |
| May 30, 2021 | 2021/23 Gaz | OM | Rejection |
| April 21, 2021 | 2021/19 Gaz | US | Registration |
ID: 141593154